GSA Capital Partners LLP has taken a significant step by acquiring 4,776 shares in CME Group Inc. during the third quarter of 2023. This purchase, disclosed in a recent 13F filing with the Securities and Exchange Commission (SEC), represents an investment of approximately $1.29 million in the financial services provider.
This acquisition comes as a part of a broader trend among institutional investors, who collectively hold 87.75% of CME Group’s stock. Notably, Caldwell Trust Co increased its holdings by 116.3% during the same period, now owning 93 shares valued at $25,000 after adding 50 shares. Other firms, including Loring Wolcott & Coolidge Fiduciary Advisors LLP and Financial Consulate Inc., have also entered new positions in CME Group, with respective investments of $27,000 and $28,000.
Insider Trading Activity
In addition to institutional investments, recent trading activity among company insiders has raised eyebrows. On February 6, 2024, CME Group’s CEO, Terrence A. Duffy, sold 25,000 shares at an average price of $269.55, totaling $6.74 million. This transaction reduced his holdings to 65,804 shares, valued at approximately $17.74 million, indicating a 27.53% decrease in his stake.
Similarly, director Dennis Suskind sold 748 shares on the same day for $224,400, reducing his ownership to 2,699 shares. Insider ownership now accounts for only 0.30% of the company’s stock, a notable decline as executives adjust their portfolios.
CME Group Financial Performance
CME Group recently reported its earnings for the fourth quarter of 2023, showcasing a solid performance. The company achieved earnings per share (EPS) of $2.77, surpassing the consensus estimate of $2.75 by $0.02. Revenue for the quarter was reported at $1.65 billion, slightly above expectations of $1.64 billion. This marks an impressive 8.1% increase in revenue year-over-year, compared to $2.52 EPS in the same quarter last year.
Looking ahead, analysts project that CME Group will post an EPS of $10.49 for the current fiscal year, indicating a positive outlook for the financial services firm.
Dividend Announcement and Analyst Ratings
CME Group has also announced an increase in its quarterly dividend, set to be paid on March 26, 2024. Shareholders on record by March 10, 2024, will receive a dividend of $1.30 per share, up from the previous $1.25. This adjustment translates to an annualized dividend of $5.20 and a dividend yield of 1.7%, with a payout ratio of 44.80%.
Analysts have recently adjusted their ratings on CME Group shares, with Morgan Stanley raising its price target from $319.00 to $340.00 and maintaining an “overweight” rating. Other firms, including Piper Sandler and Barclays, have also increased their targets, reflecting a generally positive sentiment toward the company. Currently, nine analysts rate the stock as a Buy, while six recommend holding and three suggest selling.
CME Group Inc. operates multiple major derivatives exchanges, including the Chicago Mercantile Exchange and the New York Mercantile Exchange, offering a wide range of futures and options contracts. Its services cater to a diverse clientele, including institutional investors and retail participants, solidifying its position as a key player in global financial markets.
